Peter M. Moyle

2.7k citations

66 papers · 2.1k indexed · h-index 28

Microbiology top 2%
- Antimicrobial Peptides and Activities 8
Immunology top 5%
- Immunotherapy and Immune Responses 11
Pharmaceutical Science top 5%
Infectious Diseases top 5%
Molecular Biology top 10%
- RNA Interference and Gene Delivery 15
- Advanced biosensing and bioanalysis techniques 11
- Biochemical and Structural Characterization 10
- vaccines and immunoinformatics approaches 8
Public Health, Environmental and Occupational Health
- Streptococcal Infections and Treatments 16
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 10

Co-authors: István Tóth Seyed Ebrahim Alavi Michael F. Good Peter J. Cabot Michael R. Batzloff Colleen Olive Pavla Simerská Anjuman Ara Begum
Cited by: Microbiology Immunology Pharmaceutical Science
Journals: Nanomedicine (6 papers)Bioconjugate Chemistry (4 papers)Journal of Medicinal Chemistry (4 papers)
Partner nations: Australia United States Mexico

In The Last Decade

Peter M. Moyle

65 papers receiving 2.1k citations

Peers

Countries citing papers authored by Peter M. Moyle

Since Specialization

Citations

This map shows the geographic impact of Peter M. Moyle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Moyle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Moyle more than expected).

Fields of papers citing papers by Peter M. Moyle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Moyle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Moyle. The network helps show where Peter M. Moyle may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Peter M. Moyle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter M. Moyle Line = papers co-authored together Peter M. Moyle links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Green Encapsulation of Metal Oxide and Noble Metal ZnO@Ag for Efficient Antibacterial and Catalytic Performance Industrial & Engineering Chemistry Research ·Florian Trimborn,Kamal Kishore Pant,(unknown),Peter M. Moyle,Zyta M. Ziora	2025	1
2	Transformative upcycling of fruit-vegetable waste for nutraceutical and pharmaceutical breakthroughs and circular economy evolution Process Safety and Environmental Protection ·Florian Trimborn,Peter M. Moyle,Anushree Malik,Zyta M. Ziora,Kamal Kishore Pant	2024	18
3	Efficacy of Alum-Adjuvanted Peptide and Carbohydrate Conjugate Vaccine Candidates against Group A Streptococcus Pharyngeal Infection in a Non-Human Primate Model Vaccines ·Tania Rivera-Hernández,Diane G. Carnathan,Johanna Richter,Bin Zhou,Amanda J. Cork,Petr Shipunov,Anna Henningham,Jason N. Cole,Biswa Choudhury,Peter M. Moyle,István Tóth,Michael R. Batzloff,Michael F. Good,Paresh Agarwal,Neeraj Kapoor,Victor Nizet,Guido Silvestri,Mark J. Walker	2024	0
4	Advances in, and prospects of, 3D preclinical models for skin drug discovery Drug Discovery Today ·Mohammad Imran,Peter M. Moyle,Danielle Kamato,L. E. Khoruts	2024	10
5	Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing Drug Delivery and Translational Research ·P. Macías Rodríguez,Anjuman Ara Begum,Muna Iraqi,István Tóth,Peter M. Moyle	2023	49
6	Sortase A Inhibitor Protein Nanoparticle Formulations Demonstrate Antibacterial Synergy When Combined with Antimicrobial Peptides Molecules ·Sitah Alharthi,Amirali Popat,Zyta M. Ziora,Peter M. Moyle	2023	8
7	Formulation and Biological Evaluation of Mesoporous Silica Nanoparticles Loaded with Combinations of Sortase A Inhibitors and Antimicrobial Peptides Pharmaceutics ·Sitah Alharthi,Zyta M. Ziora,Taskeen Iqbal Janjua,Amirali Popat,Peter M. Moyle	2022	15
8	Developing GLP-1 Conjugated Self-Assembling Nanofibers Using Copper-Catalyzed Alkyne–Azide Cycloaddition and Evaluation of Their Biological Activity Bioconjugate Chemistry ·Seyed Ebrahim Alavi,Peter J. Cabot,Aun Raza,Peter M. Moyle	2021	31
9	Sortase A (SrtA) inhibitors as an alternative treatment for superbug infections Drug Discovery Today ·Sitah Alharthi,Seyed Ebrahim Alavi,Peter M. Moyle,Zyta M. Ziora	2021	53
10	Supercritical Fluid Assembly of Albendazole Liposomes Targeting Gastrin-Releasing Peptide Receptor Overexpressing Tumors Nanomedicine ·Faheem Maqbool,James R. Falconer,Peter M. Moyle	2020	3
11	Optimized Methods for the Production and Bioconjugation of Site-Specific, Alkyne-Modified Glucagon-like Peptide-1 (GLP-1) Analogs to Azide-Modified Delivery Platforms Using Copper-Catalyzed Alkyne–Azide Cycloaddition Bioconjugate Chemistry ·Seyed Ebrahim Alavi,Peter J. Cabot,Lynne Bruckner,Peter M. Moyle	2020	43
12	A Self‐Adjuvanting Vaccine Platform: Optimization of Site‐Specific Sortase A Mediated Conjugation of Toll‐Like Receptor 2 Ligands onto the Carboxyl or Amino terminus of Recombinant Protein Antigens ChemPlusChem ·APARECIDO PAULA,Peter M. Moyle	2020	6
13	Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein–Fusion Combination Vaccine ACS Infectious Diseases ·APARECIDO PAULA,Tania Rivera-Hernández,Peter M. Moyle	2020	7
14	Neutralisation of adeno-associated virus transduction by human vitreous humour Gene Therapy ·I.H. Armann,Peter M. Moyle,Brett W. Stringer,Jason C. Steel,Christopher J. Layton	2020	6
15	Peptide-based targeted polymeric nanoparticles for siRNA delivery Nanotechnology ·Waleed M. Hussein,Luciana Vieira Andrade,Chang Liu,久司関,Anjuman Ara Begum,Larry M. Kasen,Peter M. Moyle,Vladimir P. Torchilin,Roger Smith,István Tóth	2019	23
16	Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency Molecular Pharmaceutics ·Seyed Ebrahim Alavi,Peter J. Cabot,Peter M. Moyle	2019	75
17	Semisynthetic, self-adjuvanting vaccine development: Efficient, site-specific sortase A-mediated conjugation of Toll-like receptor 2 ligand FSL-1 to recombinant protein antigens under native conditions and application to a model group A streptococcal vaccine Journal of Controlled Release ·APARECIDO PAULA,Tania Rivera-Hernández,Tayrine Helen Marques do Nascimento,Mark J. Walker,Peter M. Moyle	2019	22
18	Glucagon‐Like Peptide‐1 (GLP‐1)‐Based Therapeutics: Current Status and Future Opportunities beyond Type 2 Diabetes ChemMedChem ·Aikpitanyi Ikponwosa,Peter M. Moyle	2018	63
19	Bioconjugation Approaches to Producing Subunit Vaccines Composed of Protein or Peptide Antigens and Covalently Attached Toll-Like Receptor Ligands Bioconjugate Chemistry ·APARECIDO PAULA,Peter M. Moyle	2017	45
20	Biotechnology approaches to produce potent, self-adjuvanting antigen-adjuvant fusion protein subunit vaccines Biotechnology Advances ·Peter M. Moyle	2017	81

About Peter M. Moyle

Peter M. Moyle is a scholar working on Microbiology, Immunology, Public Health, Environmental and Occupational Health, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 66 papers that have together received 2.1k indexed citations. Recurring topics across this work include Streptococcal Infections and Treatments (16 papers), RNA Interference and Gene Delivery (15 papers), Immunotherapy and Immune Responses (11 papers), Advanced biosensing and bioanalysis techniques (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Biochemical and Structural Characterization (10 papers), Antimicrobial Peptides and Activities (8 papers) and vaccines and immunoinformatics approaches (8 papers). The work is most often cited by research in Microbiology (249 citations), Immunology (705 citations), Pharmaceutical Science (121 citations), Infectious Diseases (360 citations) and Molecular Biology (1.1k citations). Peter M. Moyle has collaborated with scholars based in Australia, United States and Mexico. Frequent co-authors include István Tóth, Seyed Ebrahim Alavi, Michael F. Good, Peter J. Cabot, Michael R. Batzloff, Colleen Olive, Pavla Simerská, Anjuman Ara Begum, Yu Wan and Zyta M. Ziora. Their work appears in journals such as Nanomedicine, Bioconjugate Chemistry, Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry and Current Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact